Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pain block may cut opioid use after lung surgery

NCT ID NCT07250373

Symptom relief Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two types of nerve blocks to control pain after lung surgery. About 28 adults having lung surgery will get either a Serratus Posterior Superior Intercostal Plane block or an Intercostal Nerve block. The goal is to see which block reduces pain, lowers the need for strong painkillers, and helps patients breathe better after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 28 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients over 18 years of age with lung neoplasm who are candidates for pulmonary resection surgery via Uniportal-VATS * Patients who have provided informed consent to participate in the study Exclusion Criteria: * Patients who refuse to participate in the study by not signing the informed consent; * Patients with severe obesity (BMI \> 35), history of OSAS with or without CPAP; * Patients classified as ASA \> 3, according to the system established by the American Society of Anesthesiologists; * Patients unable to understand the use of the NPR Scale or the PCA device that will be used for postoperative analgesia; * Patients with allergies to analgesic and/or anesthetic drugs; * Patients undergoing anticoagulant therapy; * Patients with a history of chronic pain; * Patients with an infection at the site where SPSIPB or ICNB will be performed; * Patients with a history of thoracic surgery and/or thoracic trauma with rib fractures on the side of surgery; * Patients with chest wall deformities and/or neuromuscular diseases that interfere with normal ventilatory function. Additionally, patients whose surgical procedure is intraoperatively converted to an open pulmonary resection will be excluded post hoc from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intercostal nerve block are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intercostal nerve block Locoregional anesthesia Lung resection procedures Post-operative pain management Serratus posterior superior intercostal plane block Uniportal video assisted thoracic surgery Uniportal-vats

Contacts and locations

Locations

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Rome, Lazio, 00135, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.